State of the art: approved and emerging JAK inhibitors for rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1822325
Abstract: ABSTRACT Introduction Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults. In the past decade, many treatments have emerged to expand the therapeutic armamentarium of rheumatologists. Among emerging treatments, Janus Kinase inhibitors… read more here.
Keywords: jak; approved emerging; rheumatoid arthritis; arthritis ... See more keywords
New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2021.1892641
Abstract: ABSTRACT Abstract introduction: The number of medications approved for AUD is small and they generally have limited efficacy. We need new pharmacotherapies for the management of AUD. Areas covered: In this review, the authors aim… read more here.
Keywords: pharmacological approaches; approaches alcohol; approved emerging; new approved ... See more keywords
Recently approved and emerging drug options for migraine prophylaxis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2102420
Abstract: ABSTRACT Introduction Migraine occupies the first position regarding the disability caused in female working population (15–49 years). Research in the field of prophylaxis in this pathology has made enormous strides in recent years. Areas covered… read more here.
Keywords: drug options; recently approved; migraine prophylaxis; approved emerging ... See more keywords
Approved and emerging treatments of malignant pleural mesothelioma in elderly patients
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2019.1678386
Abstract: ABSTRACT Introduction: Malignant pleural mesothelioma (MPM) is a rare neoplasm with asbestos exposure as the dominant etiologic agent. Owing to the long latent period following exposure, MPM is often diagnosed late in life. Despite this,… read more here.
Keywords: treatments malignant; pleural mesothelioma; malignant pleural; approved emerging ... See more keywords